Anthropic said its Claude AI, running 950 AI agents over roughly 200,000 reverse transcriptase samples in about 21 hours, identified a novel CRISPR-like enzyme system that human scientists then confir…
Anthropic announced that its Claude AI system identified a "previously unknown enzyme system" in DNA — described by CEO Dario Amodei as "a molecular machine that we suspect could represent a new gene …
Anthropic announced on 23 September that its Claude AI agents screened more than 200,000 reverse transcriptases and identified a previously uncharacterised enzyme system in bacteriophage DNA, named ar…
Anthropic announced on Wednesday that its AI model Claude autonomously discovered a new enzyme system in bacterial DNA that the company said could "represent a new gene editing mechanism" similar to C…
Anthropic announced on September 23 that roughly 950 autonomous Claude agents ran for 21 hours and screened more than 200,000 reverse transcriptases, flagging about 3,500 candidate systems and narrowi…
Anthropic announced that its Bay Area wet biology lab discovered a previously unknown enzyme system in bacteriophage DNA that behaves similarly to CRISPR, performing operations like cutting, copying, …
Anthropic announced that its Claude AI model discovered a previously unknown biological system, which it calls array-associated reverse transcriptases (ART), with features reminiscent of CRISPR, found…
Anthropic announced that its Claude AI agents autonomously discovered a novel enzyme system, which the company calls array-associated reverse transcriptases (ART), found in bacteriophages and associat…
Anthropic said its Claude model autonomously identified a previously uncharacterized enzyme system with CRISPR-like features, called array associated reverse transcriptases (ART), marking the first re…
MIT Technology Review's The Download newsletter reports that a Japanese team led by Takashi Ishiuchi, a reproductive biologist at the University of Yamanashi, used a CRISPR-based approach to remove th…
Researchers used AlphaFold AI to redesign gene-editing proteins, reducing off-target effects that cause safety concerns in therapies. The team modified key areas of Cas proteins identified by the AI t…
Colossal Biosciences CEO Ben Lamm says de-extinction is an engineering problem, not science fiction, and that the company's work on species such as the woolly mammoth, dodo, and Tasmanian tiger uses a…
Google Research is using AI to accelerate scientific discovery across genomics, neuroscience, epidemiology and climate science, according to Lizzie Dorfman, who leads science AI at the company. Dorfma…